{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:14:17Z","timestamp":1794266057000,"version":"4.9.0"},"reference-count":76,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005205","name":"Janssen Research & Development, LLC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["mAbs"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/19420862.2025.2461191","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T06:02:51Z","timestamp":1739340171000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":46,"title":["Nipocalimab, an immunoselective FcRn blocker that lowers IgG and has unique molecular properties"],"prefix":"10.1080","volume":"17","author":[{"given":"Nilufer P.","family":"Seth","sequence":"first","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xu","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"DuPrie","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Choudhury","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Sihapong","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Tyler","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Meador","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Avery","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Cochran","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Daly","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Brown","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rutitzky","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Markowitz","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujatha","family":"Kumar","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traymon","family":"Beavers","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayak","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin","family":"Chen","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viraj","family":"Parge","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Price","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Sukumaran","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Pao","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Abouzahr","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Elwood","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Duffner","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sucharita","family":"Roy","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushpa","family":"Narayanaswami","sequence":"additional","affiliation":[{"name":"Harvard Medical School","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Hubbard","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7251-9985","authenticated-orcid":false,"given":"Leona E.","family":"Ling","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42330"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00457-9"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.02.001"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00603"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00418-5"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.144998"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.09.002"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000171"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead348"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2011.01026.x"},{"key":"e_1_3_6_12_1","unstructured":"Saag KG Furst DE. Major adverse effects of systemic glucocorticoids. [Accessed 2024 May 21]. https:\/\/www.uptodate.com\/contents\/major-adverse-effects-of-systemic-glucocorticoids."},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00821-1"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2155"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.7.4580"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.537563"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1097-2765(01)00230-1"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.4.2021"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0402970101"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/985646"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.07.015"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi052628y"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200636556"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1276"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207937"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2024-eular.LBA90"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2314466"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004278"},{"key":"e_1_3_6_29_1","volume-title":"Presented at: the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) 2024 Annual Meeting","author":"Vu T","year":"2024","unstructured":"Vu T, Antozzi C, Ramchandren S, Farmakidis C, Bril V, De Bleecker J, Yang H, Minks E, Park J-S, et al. Efficacy and safety of nipocalimab in patients with generalized MG: topline results from the double-blind, placebo-controlled, randomized phase 3 Vivacity-MG3 study. Presented at: the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) 2024 Annual Meeting; 2024 Oct 15\u201318; Savannah (GA), USA."},{"key":"e_1_3_6_30_1","unstructured":"VYVGART\u24c7 HYTRULO (efgartigimod alfa and hyaluronidase-qvfc) [package insert]. argenx US Inc.; 2023."},{"key":"e_1_3_6_31_1","unstructured":"RYSTIGGO\u24c7 (rozanolixizumab-noli) [package insert]. UCB Inc.; 2023."},{"key":"e_1_3_6_32_1","unstructured":"VYVGARTTM (efgartigimod alfa-fcab) injection [package insert]. argenx US Inc.; 2021."},{"key":"e_1_3_6_33_1","unstructured":"argenx. Press release: argenx announces approval of VYVGART (efgartigimod alfa) in Japan for adults with primary immune thrombocytopenia. [Accessed 2024 Oct 30]. https:\/\/argenx.com\/news\/2024\/argenx-announces-approval-vyvgart-efgartigimod-alfa-japan-adults-primary-immune."},{"key":"e_1_3_6_34_1","unstructured":"argenx. argenx announces approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for adults with chronic inflammatory demyelinating polyneuropathy. [Accessed 2025 Jan 6]. https:\/\/argenx.com\/news\/2024\/argenx-announces-approval-of-vyvdura\u2013efgartigimod-alfa-and-hyal."},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021829"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1607"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.4.2.19397"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101718"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219247"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1302714"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33764-1"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2018.1505464"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI97911"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2013.06.035"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2016.1189049"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200501"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2023.2300155"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan1208"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.05.023"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00520"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-022-00345-9"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad381"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.176166"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181c2bde8"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00176"},{"issue":"9","key":"e_1_3_6_56_1","first-page":"1988","article-title":"A randomized, open-label study on the effect of nipocalimab on vaccine responses in healthy participants","volume":"76","author":"Cossu M","year":"2024","unstructured":"Cossu M, Bobadilla Mendez C, Jackson A, Myshkin E, Liu G, Lam E, Beier UH, Weisel K, Scott B, Leu JH, et al. A randomized, open-label study on the effect of nipocalimab on vaccine responses in healthy participants. Arthritis Rheumatol. 2024;76(suppl 9):1988.","journal-title":"Arthritis Rheumatol"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2022.2104261"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.07.016"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916930903555943"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1159\/000439002"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00880"},{"issue":"9","key":"e_1_3_6_62_1","article-title":"Post-hoc analysis of clinically relevant anti-vaccine antibodies in participants with rheumatoid arthritis treated with nipocalimab","volume":"76","author":"Yu F","year":"2024","unstructured":"Yu F, Myshkin E, Bobadilla Mendez C, Cossu M, Fei K, Wang Q, Loza MJ, Dimitrova D, Gao S. Post-hoc analysis of clinically relevant anti-vaccine antibodies in participants with rheumatoid arthritis treated with nipocalimab. Arthritis Rheumatol. 2024;76(suppl 9):1978.5.","journal-title":"Arthritis Rheumatol"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00159-9"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00077-7"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.98.18_supplement.407"},{"issue":"9","key":"e_1_3_6_66_1","first-page":"1427","article-title":"Observed and simulated pharmacokinetics and pharmacodynamics of nipocalimab, a fully human FcRn blocking monoclonal antibody, in adults with Sj\u00f6gren\u2019s disease: results from a phase 2, multicenter, randomized, placebo-controlled, double-blind study","volume":"76","author":"Liva SG","year":"2024","unstructured":"Liva SG, Zheng F, Leu JH, Sivils K, Ma K, Li H, Leonardo S, Lo K, Idokogi J, Campbell K, et al. Observed and simulated pharmacokinetics and pharmacodynamics of nipocalimab, a fully human FcRn blocking monoclonal antibody, in adults with Sj\u00f6gren\u2019s disease: results from a phase 2, multicenter, randomized, placebo-controlled, double-blind study. Arthritis Rheumatol. 2024;76(suppl 9):1427.","journal-title":"Arthritis Rheumatol"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2023.11.254"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2023.11.528"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2019.02.058"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.24891"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.202391"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003755"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4224"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1107\/S0021889807021206"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444912001308"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444910007493"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2007.05.022"}],"container-title":["mAbs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/19420862.2025.2461191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T11:45:56Z","timestamp":1765453556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/19420862.2025.2461191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/19420862.2025.2461191"],"URL":"https:\/\/doi.org\/10.1080\/19420862.2025.2461191","relation":{},"ISSN":["1942-0862","1942-0870"],"issn-type":[{"value":"1942-0862","type":"print"},{"value":"1942-0870","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=kmab20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=kmab20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-11-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2461191"}}